title: Licensed medicines, off-label use or evidence-based. Which is most important?
authors.affiliation: Laboratory for Mother and Child Health, Department of Public Health, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bonati
authors.affiliation: Department of Paediatric Pharmacology and Pharmacogenetics, CIC1426 Inserm/APHP, University Paris Diderot, Robert Debre Hospital, Paris, France.
authors.forename: Evelyne
authors.initials: E
authors.lastname: Jacqz-Aigrain
authors.affiliation: Academic Division of Child Health, University of Nottingham, Derbyshire Children's Hospital, Derby, UK.
authors.forename: Imti
authors.identifier: 0000-0002-3069-6323
authors.initials: I
authors.lastname: Choonara
mesh_terms: D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D007223:Infant; D056687:Off-Label Use
keywords: General Paediatrics; Paediatric Practice